Home > News > Nanoparticles May Detect Alzheimer's, Reversal Of Memory Loss
September 18th, 2003
Nanoparticles May Detect Alzheimer's, Reversal Of Memory Loss
Researchers have discovered for the first time in humans the presence of neurotoxic peptide assemblies that may be responsible for the memory loss found in individuals suffering from Alzheimer's disease (AD). The next step is to develop clinical diagnostics -- using nanoparticles -- to detect the amyloid beta-derived diffusible ligands (ADDLs), and effective drugs that prevent the onset of AD, delay its progression, and potentially restore cognitive function in patients with memory-related disorders, as reported in NanoBiotech News.
Detecting Cancer Earlier is Goal of Rutgers-Developed Medical Imaging Technology: Rare earth nanocrystals and infrared light can reveal small cancerous tumors and cardiovascular lesions October 21st, 2014
Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons: At the Faculty of Pharmacy of the UPV/EHU-University of the Basque Country encapsulation techniques are being developed to deliver correctly and effectively certain drugs October 20th, 2014
Non-Toxic Nanocatalysts Open New Window for Significant Decrease in Reaction Process October 19th, 2014
European Commission opens the gate towards the implementation of Nanomedicine Translation Hub October 16th, 2014